A PCR assay for the detection of Helicobacter pylori in gastric biopsy specimens with specific primers for ureC gene amplification (herein referred to as ureC PCR) was compared with other routine invasive methods (culture, the rapid-urease test, and Giemsa staining of histological sections) with samples from a group of 104 consecutive dyspeptic patients. Bacteria were found in 40 (38.5%), 38 (36.5%), 36 (34.6%), and 35 (33.7%) of the patients by ureC PCR, culture, the rapid-urease test, and Giemsa stain, respectively. Sixty-three patients had negative cultures, negative histological examinations, and negative rapid-urease test results, and 61 of these patients were also negative by ureC PCR. ureC PCR detected H. pylori in two culture-negative patients. In parallel, a PCR-based assay to detect the H. pylori cytotoxin-associated antigen (cagA) gene, a putative virulence gene, was also developed. To assess the likelihood of detection of H. pylori genes directly from gastric biopsy samples and from the corresponding H. pylori isolates, specimens from 31 patients were subjected to PCR with ureC-and cagA-targeting primers. All 31 biopsy specimens and the corresponding H. pylori isolates were positive in the ureC PCR. H. pylori strains that were cagA positive also gave positive cagA PCR fragments with biopsy specimens from the same patients. All ureC PCR-positive patients were examined; biopsy specimens from 10 of 11 (91.7%) duodenal ulcer patients harbored H. pylori cagA-positive strains, whereas 19 of 26 (73%) of those from patients with chronic gastritis only were found to be cagA positive. These findings indicate first that ureC PCR is at least as sensitive as culture for diagnosing H. pylori infection and second that the presence of the H. pylori cagA gene can also be detected directly in biopsy specimens by PCR amplification.
The bacterium Helicobacter pylori is a fastidious, microaerophilic spiral gram-negative microorganism which plays a significant role in the pathogenesis of chronic gastritis, peptic ulcer, and, with mounting evidence from recent data, gastric cancer (4) . Its worldwide distribution and high level of prevalence and the importance of associated pathologies make the elimination of H. pylori a very useful approach to treating and controlling these gastroduodenal diseases, since its eradication results in a marked reduction in the rate of recurrence of duodenal and gastric ulcer (16) 
Methods that accurately detect H. pylori infection in dyspeptic patients are therefore of major importance. Direct demonstration of H. pylori in gastric biopsy specimens is possible through the use of culture, histological examination with several stains, and assays for rapid urease activity. Culture, although labor-intensive because of the fastidious nature of the organism, is a very sensitive detection method with the advantages of specifically detecting H. pylori and making strains available for susceptibility testing. All these endoscopy-based methods require gastric biopsy specimens and are thus classified as invasive methods (14) .
Recently, assays based on PCR technology were employed to detect the presence of H. pylori DNA by using several gene targets. Although the PCR technique looks very promising, in many of the reported studies either a limited number of specimens were analyzed or gastric biopsy specimens from selected unconsecutive patients were tested (3, 5, 15, 17, 19, 25, 27) .
The cytotoxin-associated antigen (cagA) gene is an H. pylori gene that codes for a 96-to 138-kDa protein that is associated with the production of vacuolating toxin (6, 24) . The presence of H. pylori cagA-positive strains and the serological response to the CagA protein are associated with peptic ulcer disease (7-9). Recently, a higher level of prevalence of anti-CagA antibodies in sera from patients with gastric cancer has also been reported (11) .
The present study aimed (i) to comparatively evaluate PCR and other diagnostic methods (culture, rapid-urease test, and Giemsa staining of histological sections) for detection of H. pylori in biopsy specimens from 104 consecutive dyspeptic patients and (ii) to evaluate the detection of a putative virulence marker of H. pylori, the cagA gene, by PCR in biopsy specimens as well as in corresponding H. pylori isolates.
MATERIALS AND METHODS
Bacterial strains. Thirty-five H. pylori isolates were used in this study: 3 cagA-positive reference strains (NCTC 11637, ATCC 49503, and ATCC 53726), a cagA-negative reference strain (Tx30A), and 31 clinical isolates from patients. Also tested were Helicobacter mustelae NCTC 12031, Helicobacter fennelliae NCTC 11612, Helicobacter cinaedi LMG 7543, Campylobacter fetus fetus ATCC 27374, Campylobacter jejuni jejuni NCTC 11351, Campylobacter jejuni doylei NCTC 11951, Campylobacter coli NCTC 11366, Campylobacter lari NCTC 11352, C. sputorum biovar fecalis NCTC 11415, the urease-positive strain C. lari J116, and clinical isolates (St. Pieters University Hospital, Brussels, Belgium) of vari-ous urease-positive bacterial species belonging to the family Enterobacteriaceae (five Proteus mirabilis isolates, seven Klebsiella pneumoniae isolates, and one K. oxytoca isolate), as well as a few nonfermentative gram-negative bacilli (two Pseudomonas aeruginosa isolates), which were all identified by routine methods (2) . The strains were tested by PCR to assess the specificities of the primers. All strains were stored at Ϫ70ЊC in whole horse blood before being assayed by PCR.
Patients. One hundred four consecutive untreated patients undergoing upper gastroduodenal endoscopy from 1 October to 30 November 1993 at the Nouvelle Clinique de la Basilique (Brussels, Belgium) were included in the study. The population consisted of 40 males and 64 females with a mean age of 55.3 years (range, 19 to 93 years).
Endoscopy and biopsy sampling. At least five antrum and four corpus biopsy specimens were collected from each patient for the rapid-urease test (one antrum biopsy specimen), histology (three or more antrum and two or more corpus biopsy specimens), and culture (one each antrum and corpus biopsy specimens). Biopsy specimens for culture examination were dipped with sterile cotton in a semisolid agar transport medium (Portagerm; bioMérieux, Marcy l'Etoile, France). An additional antrum biopsy specimen was obtained for PCR analysis. Biopsy specimens for culture and PCR were frozen at Ϫ70ЊC until processing.
The endoscopic apparatus (Olympus GIF-IT or Fujinon UGIF-P2), including all channels, and biopsy forceps were carefully cleaned and disinfected by immersion in a 2% glutaraldehyde (Cidex; Surgikos Ltd., Livingstone, Scotland) solution for 15 min, rinsed in water, and dried after use with each patient and at the end of each endoscopic session.
Culture. Gastric biopsy specimens were ground at 10,000 rpm for 15 s with an electric tissue homogenizer (Ultraturrax, Iena, Germany) and then inoculated onto selective Columbia blood agar and incubated under microaerophilic (5% O 2 , 10% CO 2 , and 85% N 2 ) conditions at 37ЊC for up to 7 days (12). Organisms were identified as H. pylori on the basis of morphology in Gram stain and by oxidase, catalase, and rapid-urease tests (2) .
Histological examination. Paraffin-embedded tissue sections were stained with hematoxylin and eosin to grade the severity of gastritis and with Giemsa stain to detect H. pylori. The classification and grading of gastritis were made in accordance with the Sydney system (21) .
Rapid-urease test. One antrum biopsy specimen was introduced with a sterile needle into a semisolid 2% urea agar and incubated at room temperature. Results were recorded up to 4 h after inoculation (12) .
Case definition. A patient was classified as H. pylori positive on the basis of a positive culture result or both a positive rapid-urease test and a positive histological examination.
Preparation of samples for PCR amplification. Genomic DNAs were extracted from all strains by the guanidium thiocyanate method (20) . The extracted DNAs were dissolved in water, and solutions containing 25 g of DNA per ml were prepared and used throughout the study. DNAs from biopsy specimens were prepared as follows. Two hundred microliters of 0.5% N-acetyl-L-cysteine (Sigma, St. Louis, Mo.) solution was added to the biopsy specimen, which was vortexed for 5 min and held at room temperature for 5 additional min. Tubes were centrifuged for 15 min at 17,000 ϫ g. After the supernatants were discarded, biopsy specimens were resuspended in 100 l of distilled water and an equal volume of 50 mM NaOH was then added. The tubes were vortexed vigorously and spun down briefly. The mixture was overlaid with 200 l of light mineral oil (Sigma). The tubes were heated to 100ЊC for 10 to 15 min in a water bath. After cooling, 16 l of 1 M Tris-HCl, pH 7.5, was added underneath the oil layer. Samples were stored at 4ЊC until tested.
Primers. All primers were synthesized on a model 394 DNA/RNA synthesizer (Applied Biosystems, Foster City, Calif.) by the phosphoramidite coupling method and purified as described by the manufacturer. Primer sequences, primer annealing position, and expected lengths of amplified DNA products are shown in Table 1 . Primers 93275 and 93276, which target the ureC gene, are derived from the sequenced urease genes (EMBL accession no. X57132 and GenBank accession no. M60398) (3, 18) . Primers 93089 and 93261 were selected from consensus regions of the two available cagA gene sequences (GenBank accession no. L11714 and EMBL accession no. X70039) (6, 24) .
PCR conditions. Reactions were performed in a 50-l volume in a Techne PHC 3 thermocycler (New Brunswick Scientific, Edison, N.J.). Reaction mixtures containing 0.4 M each primer, 0.2 mM each deoxynucleoside triphosphate (dATP, dGTP, dTTP, and dCTP) (Boehringer Mannheim GmbH, Mannheim, Germany), and reaction buffer (100 mM Tris-HCl [pH 8.3], 500 mM KCl, 15 mM MgCl 2 , and 0.01% [wt/vol] gelatin) were overlaid with 1 drop of light mineral oil (Sigma) before addition of 10 l of test sample. The mixture was denatured at 94ЊC for 10 min and cooled on ice, and 2.5 U of Taq DNA polymerase (Boehringer) was added prior to 35 amplification cycles. For ureC amplification, cycles comprising a 2-min denaturing step at 94ЊC, a 2-min annealing step at 55ЊC, and a 2-min elongation step at 72ЊC were used (18) . The cagA amplifications were done with cycles of 1 min of denaturation at 94ЊC, 1 min of annealing at 59ЊC, and 1 min of elongation at 72ЊC. After 35 cycles, a final cycle comprising a 1-min step at the specified annealing temperature and a 10-min elongation step at 72ЊC was performed. DNA from H. pylori ATCC 53726 and a tube containing water in place of DNA were assayed in each PCR run as positive and negative controls, respectively, of the reaction. To avoid cross-contaminations, mixture preparation, sample handling, PCR amplification, and gel detection of amplified material were done in separate rooms.
Detection and analysis of amplified DNA products. Ten-microliter amounts of each PCR mixture were subjected to gel electrophoresis (2% agarose) and ethidium bromide staining for the detection of amplified DNA products. The specificities of the amplified DNA fragments were assessed by restriction endonuclease digestion for 1 h at 37ЊC in the buffer recommended by the manufacturer. All enzymes and buffers were from Gibco BRL Life Technology Ltd. (Renfrewshire, Scotland). The amplified ureC products were digested with SphI (restriction fragments of 168 and 126 bp) and NlaIII (restriction fragments of 126, 90, and 78 bp). SpeI, which generates fragments of 274 and 126 bp, and HindIII, which generates 195-, 159-, and 46-bp fragments, were used to digest the amplified cagA products. Digested samples were analyzed by electrophoresis with 3% Nusieve-1% SeaKem gels (FMC Bioproducts, Rockland, Maine) and ethidium bromide staining (22) .
RESULTS
Sensitivity and specificity of PCR assays with bacterial isolates. Tenfold serial dilutions of DNA from H. pylori ATCC 53276, starting at a concentration of 36.0 ng/l, were subjected to amplification by both primer pairs in order to assess the sensitivity of PCR detection. Both PCR assays were able to detect at least 3.6 fg of bacterial DNA, which corresponds to approximately two H. pylori genomes (23) . The specificities of PCRs with primers targeting ureC and cagA (herein referred to as ureC and cagA PCRs, respectively) were determined by testing 25 bacterial strains from closely related genera and from various urease-positive bacterial species which may occasionally occur as contaminants in gastric biopsy specimens.
ureC PCR amplified the expected 294-bp fragment from all H. pylori reference and clinical strains, but none of the other bacterial species tested showed any amplicons (Fig. 1A) .
Amplification of DNA from H. pylori ATCC 53726, ATCC 49503, and NCTC 11367 revealed the expected 400-bp PCR fragment when the two specific oligonucleotide primers targeting the cagA gene were used (Fig. 1B) . No other bacterial species tested showed any product in cagA PCR. Digestion of the ureC PCR-amplified fragment with SphI and NlaIII gave the expected restriction endonuclease patterns, as did digestion of the 400-bp amplified fragment from cagA PCR with SpeI and HindIII (data not shown).
Diagnostic assays. Thirty-eight (36.5%) of the biopsy spec- Table 2 .
The rapid-urease test was positive for 36 of the 104 (34.6%) patients' biopsy specimens. In one case, the urease test was the only positive test, while for another patient, ureC PCR was also positive. H. pylori organisms were detected by Giemsa staining in 35 (33.7%) of the specimens, being the only positive test on one occasion. The specific ureC gene fragment was amplified in biopsy specimens from 40 (38.5%) patients. The biopsy specimens of all culture-positive patients were positive by ureC PCR. Furthermore, biopsy specimens from two culture-negative patients yielded the expected 294-bp ureC fragment following PCR amplification ( Table 3) .
The comparative results obtained by all the different methods are reported in Table 3 . Culture was taken as the ''gold standard'' for H. pylori detection with biopsy specimens, in view of its high specificity and because it detected the largest number (38 patients) of H. pylori-positive patients among the routine diagnostic assays. The sensitivity, specificity, and positive and negative predictive values for ureC PCR were, respectively, 100, 97, 95, and 100%; for the rapid-urease test they were 89.5, 97, 94.4, and 94.1%; and for histology they were 89.5, 98.5, 97.1, and 94.2%.
Detection of the cagA gene. Of the 40 ureC PCR-positive biopsy specimens, 32 (including those of the two culture-negative patients) also gave amplified DNA fragments in cagA PCR. All but one biopsy specimen from peptic ulcer patients were infected with H. pylori cagA-positive strains. The biopsy specimens from 19 (73%) of the patients with gastritis only also had H. pylori cagA-positive strains, as did the biopsy specimens from the gastric cancer patient. The comparison of the frequency of cagA-positive patients between the groups of peptic ulcer and gastritis-only patients did not reveal any statistically significant difference (two-tailed Fisher's exact test; P ϭ 0.393).
Correlation between PCR amplifications with biopsy specimens and with the corresponding H. pylori isolates. In order to assess the likelihood of amplification of H. pylori genes directly from biopsy specimens, 31 available H. pylori isolates and their respective biopsy specimens were subjected in parallel to ureC and cagA PCRs. There was an excellent correlation between the results of PCR for the H. pylori isolates and the direct amplification of the ureC and cagA fragments from the corresponding biopsy specimens. The ureC fragment was amplified in all 31 H. pylori isolates as well as in their corresponding biopsy specimens. Twenty-five of the 31 isolates and the corresponding biopsy specimens showed the 400-bp cagA product. On the other hand, the biopsy specimens corresponding to all six cagA PCR-negative isolates were also negative (Fig. 1) .
DISCUSSION
In this study, we have investigated a group of consecutive dyspeptic patients by endoscopy and gastric biopsies for H. pylori infection. We found that ureC PCR was at least as sensitive as culture for detecting H. pylori infection in patients. All culture-positive patients were also ureC PCR positive. The rapid-urease test and histological examinations of biopsy specimens detected H. pylori infection in slightly fewer patients than did culture but they still yielded good specificity, although they gave some false-positive results (two and one, respectively). Overall, our results are in good agreement with other recent data for comparisons of different routine tests for H. pylori in which Giemsa staining of histological sections (26) or the agreement among all the tests was taken as the gold standard (13) . In both studies PCR assays detected H. pylori infection in a higher percentage of patients. ureC and cagA PCRs were able to detect up to the equivalent of two H. pylori genomes in a sample, which is in the same range of detection as that described for other PCR assays for H. pylori (5, 15, 25) . However, our assay was more sensitive than the one reported in which the same ureC primers but shorter steps in each cycle (1 min) were used (3).
The apparent lack of specificity of ureC PCR may actually relate to the use of culture as the gold standard for comparison. In our study, two patients who each had culture-negative spec- 
a Biopsy specimens from 104 consecutive dyspeptic patients were tested. b Numbers in parentheses are numbers of patients with chronic active gastritis. Gastritis was defined according to reference 21. A total of 57 patients had chronic gastritis; 33 of these had chronic active gastritis.
imens had biopsy specimens which yielded amplifiable ureC PCR products. For one of the patients, the rapid-urease test was also found to be positive and the histological examination revealed chronic gastritis; the patient had a history of duodenal ulcer and of H. pylori infection. At the time that endoscopy was performed, the patient had received a 7-day course of erythromycin for an upper respiratory tract infection, and this could probably have resulted in the suppression of the organisms to levels undetectable by culture and histology. The second patient had a normal gastric mucosa at histology, and the positive PCR result could possibly reflect a recent H. pylori infection or a cross-contamination in the laboratory or perhaps from the endoscopic apparatus.
The specificity of the PCR assay with the ureC primers was once more verified (3) since ureC amplifications were obtained only with H. pylori, while none of the other urease-positive or related bacteria that were tested gave the expected amplified DNA products. The results of PCR amplification directly from biopsy specimens and from the H. pylori strains subsequently isolated from them were perfectly correlated. No false-positive or false-negative results were found for biopsy specimens amplified by the ureC or cagA primers, suggesting the absence of inhibitory substances in gastric biopsy specimens.
The CagA protein is a surface immunodominant antigen (1) with a variable molecular mass of 96 to 138 kDa depending on the number of intragenic repeats (6, 24) . Although its function has not yet been established, the CagA protein is present in 60 to 80% of H. pylori strains, and it is found in close association with the production of vacuolating cytotoxin (7, 9) . Its frequency in H. pylori strains isolated from peptic ulcer patients is greater than in those isolated from patients with gastritis only (8) . Anti-CagA antibodies in serum (immunoglobulin G) and in supernatants from gastric biopsy cultures (immunoglobulins G and A) have shown that CagA is produced in vivo (7, 10, 11) and that this protein is also detected more frequently in peptic ulcer patients than in gastritis-only patients (7, 8, 10) . There is also a high percentage of detection of anti-CagA antibodies in gastric cancer patients (11) .
In this study, the 400-bp cagA amplified DNA fragment was found in the biopsy specimens from 32 (80.0%) of the 40 ureC PCR-positive patients. Similar frequencies of cagA detection were found for a selected series from the same population (8) and in other serological studies of CagA (1, 28) . Although all H. pylori-positive peptic ulcer patients except one were infected with H. pylori cagA-positive strains, we could not demonstrate any significant difference between the frequency of cagA-positive strains among infected patients with duodenal or gastric ulcer and that among subjects with gastritis only. However, this analysis could probably have been impaired by the small number (11 patients) of peptic ulcer patients evaluated.
In conclusion, we found that the PCR assay targeting the ureC gene in biopsy specimens proved at least as sensitive as culture for detecting H. pylori infection in patients. In addition, although we do not yet have a comprehensive survey of posttreatment patients, we think that the ureC PCR could constitute a very useful diagnostic tool for treatment follow-up, at which time the number of bacteria in the gastric mucosa is usually small and may go undetected by culture or by other diagnostic methods. The amplification of H. pylori genes directly from biopsy specimens matched closely their detection in the corresponding H. pylori isolates. This study also showed that PCR has a potential value for studying cagA and possibly other virulence genes directly from biopsy specimens by PCR, allowing rapid determination of whether patients are at high risk for peptic ulcer.
